Henning Wege

Henning Wege (ID: 31648) is a researcher at the University Medical Center Hamburg-Eppendorf, affiliated with the I. Medical Clinic and Polyclinic. His work focuses on hepatocarcogenesis and immunotherapy for liver cancers.

• Key Research Areas: Hepatocellular Carcinoma (HCC), Inflammatory Signaling Pathways, Immuno-Oncology, Metabolomics, Precision Medicine

Publications (103 total) include groundbreaking studies on:

• Immunotherapy combinations (atezolizumab/bevacizumab vs lenvatinib)
• Liquid biopsy for early HCC detection
• Sex-related efficacy differences in HCC treatment
• Management of immunotherapy-induced liver injury

His research contributes to the Neuroscience, Immunology/Infection (C3i), and Oncology Research (UCCH) networks at UKE. Current projects investigate molecular interactions driving liver cancer development through the Characterization of functional interactions between inflammatory and oncogenic-permissive signaling pathways in hepatocarcinogenesis (C05+) initiative.